David Happel

Insider Reports History

Location
Novato, CA
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Happel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. President & CEO, Director Series A Common Stock 689,722 $2,193,315 $3.18 21 Jul 2025 Direct
Sagimet Biosciences Inc. President & CEO, Director Stock Option (Right to Buy) 472,000 06 Feb 2025 Direct

Insider Reports Filed by David Happel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMT Sagimet Biosciences Inc. 21 Jul 2025 1 -$598,115 4 President & CEO, Director 23 Jul 2025, 16:16
SGMT Sagimet Biosciences Inc. 06 Feb 2025 2 $0 4 President & CEO, Director 07 Feb 2025, 16:43
SGMT Sagimet Biosciences Inc. 26 Mar 2024 1 +$63,731 4 President & CEO, Director 28 Mar 2024, 16:08
SGMT Sagimet Biosciences Inc. 07 Dec 2023 1 +$6,560 4 President & CEO, Director 08 Dec 2023, 16:05
SGMT Sagimet Biosciences Inc. 17 Nov 2023 1 $0 4 President & CEO, Director 21 Nov 2023, 16:21
SGMT Sagimet Biosciences Inc. 16 Nov 2023 1 +$1,386 4 President & CEO, Director 20 Nov 2023, 21:59
SGMT Sagimet Biosciences Inc. 18 Jul 2023 2 $0 4 President & CEO, Director 20 Jul 2023, 16:15
SGMT Sagimet Biosciences Inc. 13 Jul 2023 0 $0 3 President & CEO, Director 13 Jul 2023, 21:01